AI assistant
Cytosorbents Corp — Director's Dealing 2013
Jul 17, 2013
34501_dirs_2013-07-17_8ebd7d5e-e9d2-4b73-ace1-a5b9d349f1df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2013-04-04
Reporting Person: Chan Phillip P. (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-21 | Convertible Note | $0.125 | P | Acquired | 2014-06-21 | Common Stock (400000) | Direct | |
| 2013-06-21 | Warrants | $0.15 | P | 1 | Acquired | 2018-06-21 | Common Stock (200000) | Direct |
| 2013-04-04 | Stock Option | $0.115 | A | 1650000 | Acquired | 2023-04-04 | Common Stock (1650000) | Direct |
Footnotes
F1: The Warrant is exercisable upon the earlier of either (i) June 21, 2014, or (ii) the date on which the total outstanding principal and interest of the Convertible Note has been converted into Common Stock of the Company per the terms of the warrants section in the Note agreement as disclosed on the Company's Current Report on Form 8-K filed with the SEC on June 27, 2013.
F2: The Warrant was issued in connection with the issuance of the Convertible Note for $50,000 in cash.
F3: The options will become exercisable based on the achievement of certain milestones connected to the Company's operations, subject to approval by the Board of Directors.
F4: Mr. Chan was issued the stock options as compensation for services rendered.